Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Sunshine Biopharma (SBFM) Shares Repurchased (2016 - 2024)

Sunshine Biopharma (SBFM) has disclosed Shares Repurchased for 10 consecutive years, with $3.1 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Shares Repurchased rose 519.48% year-over-year to $3.1 million, compared with a TTM value of $3.1 million through Dec 2024, up 480.19%, and an annual FY2024 reading of $3.1 million, up 480.19% over the prior year.
  • Shares Repurchased was $3.1 million for Q1 2024 at Sunshine Biopharma, up from $34321.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $3.1 million in Q1 2024 and bottomed at $34321.0 in Q3 2023.
  • Average Shares Repurchased over 3 years is $944948.5, with a median of $302911.0 recorded in 2022.
  • The sharpest move saw Shares Repurchased soared 411.94% in 2023, then surged 519.48% in 2024.
  • Year by year, Shares Repurchased stood at $99000.0 in 2022, then plummeted by 65.33% to $34321.0 in 2023, then skyrocketed by 9047.9% to $3.1 million in 2024.
  • Business Quant data shows Shares Repurchased for SBFM at $3.1 million in Q1 2024, $34321.0 in Q3 2023, and $506822.0 in Q1 2023.